ODDB.org: Open Drug Database

Janssen-Cilag AG - Concerta 27 mg, Retardtabletten

Swissmedic Registration	56249	Sequence	04
Product name	Concerta 27 mg	Description	Retardtabletten
ATC-Classification	N06BA04	ATC-Description	Methylphenidate
Introduction of Sequence	03.04.2007

Composition

methylphenidati hydrochloridum 27 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum K 29-32, acidum succinicum, acidum stearicum, E 321, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), natrii chloridum corresp. natrium 7.08 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 4.9 mg, hypromellosum, E 171, triacetinum, E 172 (nigrum), macrogolum 400, cera carnauba, Drucktinte: E 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto.

Packungsbestandteile

Galenic Form

Delayed release tablets

Active Agent	Dose
Methylphenidate Hydrochloride	27 mg

BAG: Active Agent	Dose
Methylphenidate Hydrochloride	27 mg

Inactive agents	Dose	additional_information



Acidum Phosphoricum Concentrate

Succinic Acid


		color.
		Drucktinte

Hypromellosum
Lactose Monohydrate		Überzug
Macrogol	400
Sodium Chloride
Poloxamer	188
	29-32

Propylenglycol

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
046	30 Tablet(s)	36.71	56.15	A+	SL	No
048	60 Tablet(s)	64.61	86.30	A+	SL	No

2025	©ywesee GmbH